FDA Foreign Trials Proposed Reg Criticized As Silent On Conflict Of Interest
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed rule for accepting data from foreign clinical trials not conducted under INDs fails to require investigator conflict-of-interest disclosure to trial participants, Public Citizen’s Lurie says in commentary appearing in The Lancet. Rule also does not require sponsors to publish trial results, he notes.